RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/26109379http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/26109379http://www.w3.org/2000/01/rdf-schema#comment"T-cell trafficking at vascular sites has emerged as a key step in antitumour immunity. Chemokines are credited with guiding the multistep recruitment of CD8(+) T cells across tumour vessels. However, the multiplicity of chemokines within tumours has obscured the contributions of individual chemokine receptor/chemokine pairs to this process. Moreover, recent studies have challenged whether T cells require chemokine receptor signalling at effector sites. Here we investigate the hierarchy of chemokine receptor requirements during T-cell trafficking to murine and human melanoma. These studies reveal a non-redundant role for Gαi-coupled CXCR3 in stabilizing intravascular adhesion and extravasation of adoptively transferred CD8(+) effectors that is indispensable for therapeutic efficacy. In contrast, functional CCR2 and CCR5 on CD8(+) effectors fail to support trafficking despite the presence of intratumoral cognate chemokines. Taken together, these studies identify CXCR3-mediated trafficking at the tumour vascular interface as a critical checkpoint to effective T-cell-based cancer immunotherapy."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.org/dc/terms/identifier"doi:10.1038/ncomms8458"xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Matsuzaki J."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Luster A.D."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Frelinger J.G."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Evans S.S."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Gajewski T.F."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Odunsi K."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Fisher D.T."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Muhitch J.B."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Gaulin N.B."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Ku A.W."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Mikucki M.E."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/author"Skitzki J.J."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/date"2015"xsd:gYear
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/name"Nat Commun"xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/pages"7458"xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/title"Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints."xsd:string
http://purl.uniprot.org/citations/26109379http://purl.uniprot.org/core/volume"6"xsd:string
http://purl.uniprot.org/citations/26109379http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/26109379
http://purl.uniprot.org/citations/26109379http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/26109379
http://purl.uniprot.org/uniprot/#_A0A0A6YWF2-mappedCitation-26109379http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26109379
http://purl.uniprot.org/uniprot/#_A0A0A6YXM4-mappedCitation-26109379http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26109379
http://purl.uniprot.org/uniprot/#_A0A1L1SS26-mappedCitation-26109379http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26109379